OrbusNeich stent generates promising six-month data; Natus Medical revenue soars;

 @FierceMedDev:  Shoe-mounted lever could power artificial heart pumps. More | Follow @FierceMedDev

 @MarkHFierce: Check out FierceDrugDelivery's latest - a great look at some advances in nanotech drug delivery. Special report | Follow @MarkHFierce

 @DamianFierce:  PRA is lining up to go public, filing a confidential draft with the SEC. Article | Follow @DamianFierce

> OrbusNeich says its Genous Stent generated a much lower rate of binary restenosis versus bare metal stents after six months, in patients with low-risk acute coronary syndrome. Release

> Syntermed gained the FDA's 510(k) clearance for its new Emory cardiac Toolbox 4.0, which creates a game changing environment for nuclear cardiac labs. Item

> Galt Medical's layoffs in Texas will eliminate 139 jobs. Story

> Natus Medical ($BABY) produced nearly $86 million in revenue during its fiscal 2013 first quarter, up from $59.4 million the year before. And net income hit $3.4 million, versus just $289,000 over the same period in 2012. Release

> Welch Allyn plans to showcase a new blood pressure cuff and other technology at the National Teaching Institute & Critical Care Exposition this week in Boston. Release

> Researchers at the University of Limerick developed a new metal for medical devices such as stents that could help make them more visible inside the body under an x-ray. Item

> Life Technologies ($LIFE) gained approval to use a line of genetic analyzers in Mexico for diagnostics. Item

Biotech News

 @FierceBiotech:  Life sciences VC firm launches 'crowdfunding' site for limited crowd. More | Follow @FierceBiotech

 @JohnCFierce: Pentagon advisor pocketed biotech's cash while promoting its interests - via LATimes. Report | Follow @JohnCFierce

 @RyanMFierce: Interesting 'Open Research Exchange' platform debuts for creating outcome measures from the crowd. Release | Follow @RyanMFierce

> Elan orchestrates $693M biotech buyout, $90M spinout in deal frenzy. Report

> Effector Therapeutics snags $45M venture round from A-list backers. News

Pharma News

 @FiercePharma: Biopharma's 20 highest-paid CEOs. Our latest special report on exec pay. Report | Follow @FiercePharma

 @EricPFierce: AstraZeneca rides Crestor to top of cardio drug list. Special report | Follow @EricPFierce

> Women want Apotex to pay for unwanted pregnancies. Article

> Actavis nabs Warner Chilcott in a $8.5B stock swap. News

> JVs like Pfizer, Hisun hookup provide Chinese companies shot at Western markets. Report

CRO News

> Nordion inks CMO deal with Navidea. Report

> After successful IPO, Quintiles plots 400 job cuts. Item

> PRA winds up for IPO. News

> Quintiles signs on to help Merck KGaA right the R&D ship. More

> PPD's BioDuro opens Shanghai discovery lab. Story

>WuXi's revenue jumps 11.7% in strong Q1. Article

Biotech IT News

> Drugmaker UCB taps IBM for digital medicine effort. Article

> InSilico Genomics grabs $1.5M for fledgling bioinformatics biz. Report

> Life sciences VC firm launches 'crowdfunding' site for limited crowd. Article

> Sanofi hunts for clinical trial recruits in growing social network. Story

> Merck targets docs with revamped U.K. website and healthcare apps. News